Evolus Inc . (NASDAQ:EOLS), a medical aesthetics firm specializing in neurotoxins and dermal fillers with a market capitalization of $733…
The Financial institution of Italy has revised its progress projections for the nation's economic system, now anticipating a 0.7% growth…
HAVANA (Reuters) - Cubans nonetheless reeling from months of hours-long blackouts now have a brand new drawback on their arms:…
Investing.com -- The euro has suffered a bruising encounter in opposition to the greenback this 12 months, however may see…
Non-public Medicare plans should cowl Biogen's ALS drug, US company says
U.As we speak - Try U.As we speak's prime three information tales over the previous day. XRP breakout would possibly…
Kristi Spencer Altshuler, Senior Vice President at Donegal Group Inc. (NASDAQ:DGICA), just lately bought 200 shares of the corporate's Class…
Editas Drugs Inc. (NASDAQ:EDIT), a U.S. small & mid-cap biotechnology firm, is navigating a important juncture in its growth of…
By Rodrigo Campos (Reuters) -International traders added a web $19.2 billion to their rising market portfolio holdings in November, with…
By Aaditya GovindRao (Reuters) -Australia's Insignia Monetary stated on Friday it has acquired a non-binding takeover all-cash proposal from non-public…